A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

被引：0
|
作者：
Syma Iqbal
Cathryn Rankin
Heinz-Josef Lenz
Philip J. Gold
Syed A. Ahmad
Anthony B. El-Khoueiry
Michael J. Messino
Randall F. Holcombe
Charles D. Blanke
机构：
[1] University of Southern California,Norris Comprehensive Cancer Center
[2] Southwest Oncology Group Statistical Center,Barrett Center, Department of Surgery
[3] Swedish Cancer Institute,undefined
[4] University of Cincinnati,undefined
[5] Southeast Cancer Control Consortium,undefined
[6] Inc. CCOP,undefined
[7] Cancer Care of WNC,undefined
[8] University of California at Irvine,undefined
[9] Chao Family CCC,undefined
[10] University of British Columbia,undefined
[11] and British Columbia Cancer Agency,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Gemcitabine; Capecitabine; Cholangiocarcinoma; Gallbladder; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1595 / 1602
页数：7
相关论文
共 50 条
  • [21] Phase II study of hydroxyurea for unresectable meningioma (Southwest Oncology Group S9811)
    Swinnen, L. J.
    Rankin, C.
    Rushing, E. J.
    Laura, H. F.
    Damek, D. M.
    Barger, G. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] A phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma
    Cho, JY
    Nam, JS
    Park, MS
    Yu, JS
    Paik, YH
    Lee, SJ
    Lee, DK
    Yoon, DS
    YONSEI MEDICAL JOURNAL, 2005, 46 (04) : 526 - 531
  • [23] PHASE-II TRIAL OF DIMETHYLTRIAZENOIMIDAZOLE CARBOXAMIDE IN PATIENTS WITH METASTATIC CARCINOID - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUKOWSKI, RM
    TANGEN, CM
    PETERSON, RF
    TAYLOR, SA
    RINEHART, JJ
    EYRE, HJ
    RIVKIN, SE
    FLEMING, TR
    MACDONALD, JS
    CANCER, 1994, 73 (05) : 1505 - 1508
  • [24] SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
    Ben-Josef, Edgar
    Guthrie, Katherine A.
    El-Khoueiry, Anthony B.
    Corless, Christopher L.
    Zalupski, Mark M.
    Lowy, Andrew M.
    Thomas, Charles R., Jr.
    Alberts, Steven R.
    Dawson, Laura A.
    Micetich, Kenneth C.
    Thomas, Melanie B.
    Siegel, Abby B.
    Blanke, Charles D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) : 2617 - U57
  • [25] Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer
    Meyerhardt, Jeffrey A.
    Zhu, Andrew X.
    Stuart, Keith
    Ryan, David P.
    Blaszkowsky, Lawrence
    Lehman, Nicole
    Earle, Craig C.
    Kulke, Matthew H.
    Bhargava, Pankaj
    Fuchs, Charles S.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (02) : 564 - 570
  • [26] Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer
    Jeffrey A. Meyerhardt
    Andrew X. Zhu
    Keith Stuart
    David P. Ryan
    Lawrence Blaszkowsky
    Nicole Lehman
    Craig C. Earle
    Matthew H. Kulke
    Pankaj Bhargava
    Charles S. Fuchs
    Digestive Diseases and Sciences, 2008, 53 : 564 - 570
  • [27] A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer A Hoosier Oncology Group Study
    Cardenes, Higinia R.
    Moore, Annette M.
    Johnson, Cynthia S.
    Yu, Menggang
    Helft, Paul
    Chiorean, Elena G.
    Vinson, Jacob
    Howard, Thomas J.
    Stephens, Anthony W.
    Tai, D. Fritz
    Loehrer, Patrick J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 460 - 465
  • [28] Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study
    Wolfram E. Samlowski
    Holly Gundacker
    J. Philip Kuebler
    Jeffrey K. Giguere
    Glenn M. Mills
    David E. Schuller
    John F. Ensley
    Investigational New Drugs, 2001, 19 : 311 - 315
  • [29] Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group Phase II study
    Samlowski, WE
    Gundacker, H
    Kuebler, JP
    Giguere, JK
    Mills, GM
    Schuller, DE
    Ensley, JF
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (04) : 311 - 315
  • [30] A Phase II Study of Gemcitabine and Capecitabine in Advanced Cholangiocarcinoma and Carcinoma of the Gallbladder: A Single-Institution Prospective Study
    Renuka V. Iyer
    John Gibbs
    Boris Kuvshinoff
    Marwan Fakih
    James Kepner
    Nancy Soehnlein
    David Lawrence
    Milind M. Javle
    Annals of Surgical Oncology, 2007, 14 : 3202 - 3209
12345